Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| A549 | IC50 | > 50 μM | Cytotoxicity against human A549 cells after 4 days under normal conditions by MTT assay | [PMID: 25571795] |
| A549 | IC50 | 0.8 μg/mL | Antiproliferative activity against human A549 cells assessed as inhibition of cell viability by MTT assay | [PMID: 32223924] |
| A549 | IC50 | 6.57 μM | Cytotoxicity against human A549 cells after 4 days under glucose-starved conditions by MTT assay | [PMID: 25571795] |
| HeLa | EC50 | > 100 μM | Cytotoxicity against human HeLa cells assessed as reduction in cell viability after 48 hrs by WST-8 assay | [PMID: 28754364] |
| HeLa | IC50 | 572.7 μM | Cytotoxicity against human HeLa cells assessed as reduction in cell viability by MTT assay | [PMID: 30237124] |
| HepG2 | IC50 | 2.8 μg/mL | Antiproliferative activity against human HepG2 cells assessed as inhibition of cell viability by MTT assay | [PMID: 32223924] |
| HL-60 | EC50 | 12 μM | Cytotoxicity against human HL60 cells assessed as reduction in cell viability after 48 hrs by WST-8 assay | [PMID: 28754364] |
| MDA-MB-231 | IC50 | 1.1 μg/mL | Antiproliferative activity against human MDA-MB-231 cells assessed as inhibition of cell viability by MTT assay | [PMID: 32223924] |
| MRC5 | IC50 | 2.1 μM | Antiviral activity against HCMV in MRC5 cells by plaque reduction assay | [PMID: 17239594] |
| PANC-1 | IC50 | 2.2 μM | Growth inhibition of human PANC1 cells in nutrient-deprived medium incubated for 24 hrs by MTT assay | [PMID: 30878830] |
| RAW264.7 | IC50 | 0.26 mM | Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs | [PMID: 18986199] |
11 records · Scroll to view more